BOSTON MA, February 7, 2018 – Shimmer Research, a leading provider of medical grade wearable wireless sensors, announced today its NeuroLynQ platform was used in a first of its kind study by Ipsos to measure the non-conscious response to all commercials during the 2018 Super Bowl in real time. Ipsos, a global market research firm, invited 45 football fans from both teams to watch the game in a theatre in New York City on Sunday, February 4, 2018. Each participant wore the NeuroLynQ sensor for the full duration of the game – over four hours. The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience’s responses.
Ipsos used NeuroLynQ to measure the nonconscious response of the audience to every commercial throughout the game and rank the different ads according to their proprietary Super Score. Real-time analysis was available from the sensors, allowing Ipsos to tweet about results during the game and generate a full ranking of all the ads within hours of the end of the game. (https://www.ipsos.com/en-us/news-polls/2018-super-bowl-neuro-best-commercials-ranking).
“Neuromarketing has long been too costly and slow to become widely used,” according to Geoffrey Gill, President of Shimmer Americas. “The NeuroLynQ platform is helping researchers breakthrough this barrier with cost-effective, quick analysis, that can be easily layered into more traditional research.”
For more information on this news release or the NeuroLynQ solution, please contact:
Shimmer Research:
USA – Geoffrey Gill, ggill@shimmersensing.com, (617) 945- 2628
Ireland – Martina Donohue, mdonohue@shimmersensing.com, + 353 1 6875760
Ipsos: Elissa Moses, elissa.moses@ipsos.com, (203) 216-3294
Pic left: Shimmer NeuroLynQ sensor
Shimmer Research: Shimmer is a leading technology company providing clinical-grade wearable wireless sensing technology. The company’s award-winning platform enables enterprises to reduce risk, cost, and time to market for sensor-based digital health solutions. Shimmer Research offers consultancy, design, customization, and volume manufacture for a full range of wearable sensor technology to provide high quality, scientifically reliable biophysical and movement data in real-time. This unlocks the potential for analysis and interpretation of sensed data specific to the person and creates an unprecedented level and access to personal digital health information, with the goal of improving healthcare outcomes. Shimmer’s technology is trusted and utilized by the world’s brightest startups, Fortune 500 companies, and leading Universities in over 65 countries worldwide. Deployments include an FDA approved biophysical application in the US, a telerehabilitation solution in Spain, and player tracking and performance management solution in the UK and Ireland. Established in 2008, with headquarters in Dublin, Ireland and with offices in Boston and Kuala Lumpur, Shimmer Research offers wearable wireless sensing technology that overcomes the challenges of size, wearability, reliable communications and low power consumption. For more information visit: www.shimmersensing.com
